Join to View Full Profile
640 Jackson StSt. Paul, MN 55101
Phone+1 651-254-3448
Fax+1 651-254-3470
Join Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 2 invites waiting! - Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Kurt Demel, MD is an oncologist in St. Paul, Minnesota. He is currently licensed to practice medicine in Minnesota, Wisconsin, and Rhode Island. He is an Assistant Professor at University of Minnesota Medical School,.
Education & Training
Rhode Island Hospital/Brown University HealthFellowship, Hematology and Medical Oncology, 2003 - 2006
Christ HospitalResidency, Internal Medicine, 2000 - 2002
University of WashingtonResidency, Radiation Oncology, 1999 - 2000- Christ HospitalInternship, Internal Medicine, 1998 - 1999
University of Cincinnati College of MedicineClass of 1998
Certifications & Licensure
MN State Medical License 2006 - 2027
OH State Medical License 1999 - 2027
WI State Medical License 2006 - 2027
RI State Medical License 2003 - 2006
WA State Medical License 1999 - 2000
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2012, 2014, 2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2014, 2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2014, 2017
Publications & Presentations
PubMed
- 18 citationsSynchronous development of acute myeloid leukemia in recipient and donor after allogeneic bone marrow transplantation: report of a case with comments on donor evaluation.Lewis Glasser, Aurelia Meloni-Ehrig, Wesley Olando Greaves, Kurt C. Demel, James N. Butera
Transfusion. 2009-03-01 - 70 citationsAnti-CD3 x anti-epidermal growth factor receptor (EGFR) bispecific antibody redirects T-cell cytolytic activity to EGFR-positive cancers in vitro and in an animal model.Ursula Reusch, Magesh Sundaram, Pamela A. Davol, Sarah D. Olson, James B. Davis
Clinical Cancer Research. 2006-01-01 - 33 citationsLack of bleeding in patients with severe factor VII deficiencyJ. Mark Barnett, Kurt C. Demel, Anthony Mega, James N. Butera, Joseph D. Sweeney
American Journal of Hematology. 2005-02-01
